FK-1706

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameFK-1706

Drug Alias Nametacrolimus derivative (Astellas)FK-1706FR-131706

ClassificationSmall molecules

Mechanisms of ActionNerve growth factor receptors agonistsMitogen-activated protein kinase stimulantsNeuroprotectants +[4]

TargetsMitogen-activated protein kinaseNerve growth factor receptorsPeptidyl-prolyl cis-trans isomerase FKBP4

Therapy Area/IndicationsNervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsNervous System Diseases

ATC CodeN/A